3IP
ABBV icon

3Chopt Investment Partners’s AbbVie ABBV Stock Holding History

3Chopt Investment Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57M Sell
14,191
-1,047
-7% -$225K 0.67% 34
2026
Q1 		$3.31M Sell
15,238
-296
-2% -$65.7K 0.76% 27
2025
Q4 		$3.55M Buy
15,534
+155
+1% +$35.3K 0.8% 27
2025
Q3 		$3.56M Buy
15,379
+440
+3% +$89.6K 0.81% 27
2025
Q2 		$2.77M Buy
14,939
+413
+3% +$76.8K 0.67% 35
2025
Q1 		$3.04M Buy
14,526
+771
+6% +$150K 0.8% 33
2024
Q4 		$2.44M Buy
13,755
+387
+3% +$71.2K 0.84% 38
2024
Q3 		$2.64M Buy
13,368
+338
+3% +$63.1K 0.94% 36
2024
Q2 		$2.23M Buy
13,030
+2,235
+21% +$370K 0.68% 38
2024
Q1 		$1.97M Buy
10,795
+1,494
+16% +$257K 0.81% 42
2023
Q4 		$1.44M Buy
+9,301
New +$1.36M 0.53% 53
2023
Q3 		– Sell
-7,502
Closed -$1.01M – 58
2023
Q2 		$1.01M Sell
7,502
-325
-4% -$47.7K 0.51% 56
2023
Q1 		$1.25M Buy
7,827
+781
+11% +$119K 0.66% 51
2022
Q4 		$1.14M Buy
+7,046
New +$1.08M 0.62% 49

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

3Chopt Investment Partners's ABBV Position: Q2 2026 in Review

3Chopt Investment Partners reduced its AbbVie (ABBV) stake by 6.9% in Q2 2026, selling an estimated $225K and leaving 14,191 shares worth $3.57M. The position accounts for 0.67% of the portfolio, ranked #34.

3Chopt Investment Partners first reported a position in ABBV in Q4 2022 and has held it in 14 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • 3Chopt Investment Partners held 14,191 shares of AbbVie worth $3.57M as of Q2 2026.
  • 3Chopt Investment Partners sold 1,047 AbbVie shares in Q2 2026, an estimated $225K.
  • AbbVie made up 0.67% of 3Chopt Investment Partners's portfolio in Q2 2026, its #34 holding.
  • 3Chopt Investment Partners first reported a position in AbbVie in Q4 2022 and has held it in 14 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on 3Chopt Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.